Skip to main content

Advertisement

SpringerLink
Log in

Monitoring response to imatinib using MRI signals in aggressive fibromatosis

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Kasper B, Dimitrakopoulou-Strauss A, Strauss LG, Hohenberger P. Positron emission tomography in patients with aggressive fibromatosis/desmoid tumours undergoing therapy with imatinib. Eur J Nucl Med Mol Imaging 2010;37(10):1876–82.

    Article  PubMed  Google Scholar 

  2. Lee JC, Thomas JM, Phillips S, Fisher C, Moskovic E. Aggressive fibromatosis: MRI features with pathologic correlation. AJR Am J Roentgenol 2006;186(1):247–54.

    Article  PubMed  Google Scholar 

  3. Castellazzi G, Vanel D, Le Cesne A, Le Pechoux C, Caillet H, Perona F, et al. Can the MRI signal of aggressive fibromatosis be used to predict its behavior? Eur J Radiol 2009;69(2):222–9.

    Article  CAS  PubMed  Google Scholar 

  4. Cherry SR. Multimodality imaging: beyond PET/CT and SPECT/CT. Semin Nucl Med 2009;39(5):348–53.

    Article  PubMed  Google Scholar 

  5. Wehrl HF, Judenhofer MS, Wiehr S, Pichler BJ. Pre-clinical PET/MR: technological advances and new perspectives in biomedical research. Eur J Nucl Med Mol Imaging 2009;36 Suppl 1:S56–68.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic and Interventional Radiology, University Hospital of Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Germany

    Alexander Walter Sauter & Marius S. Horger

  2. Department of Oncology and Hematology, Comprehensive Cancer Center North, University Medical Center Schleswig-Holstein, Arnold-Heller-Str. 3, Building 11, 24105, Kiel, Germany

    Joerg T. Hartmann

Authors
  1. Alexander Walter Sauter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joerg T. Hartmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marius S. Horger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexander Walter Sauter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sauter, A.W., Hartmann, J.T. & Horger, M.S. Monitoring response to imatinib using MRI signals in aggressive fibromatosis. Eur J Nucl Med Mol Imaging 38, 406–407 (2011). https://doi.org/10.1007/s00259-010-1651-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-010-1651-6

Keywords

Search

Navigation